No Data
Maccura Biotechnology (300463.SZ) products have obtained IVDR CE certification.
Maccura Biotechnology (300463.SZ) announced that four of its chemiluminescent reagent products have recently received certification from the EU notification Institutions...
Maccura BiotechnologyLtd (SZSE:300463) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Rallies 7.6% This Past Week
Maccura Biotechnology (300463.SZ): Currently, there are no corresponding overseas Orders.
On February 21, Gelonghui reported that Maccura Biotechnology (300463.SZ) stated on the investor interaction platform that the company has completed the development of monkeypox detection reagents based on fluorescence PCR technology and digital PCR technology under its molecular diagnostic platform, and the two aforementioned products have obtained EU CE certification, but have not yet obtained domestic product registration certificates, and currently there are no corresponding overseas Orders.
A Piece Of The Puzzle Missing From Maccura Biotechnology Co.Ltd's (SZSE:300463) Share Price
Maccura Biotechnology (300463.SZ): Currently, there are no specific plans to invest in AI diagnosis or information technology product companies.
On February 17th, Gelonghui reported that Maccura Biotechnology (300463.SZ) stated on the investor interaction platform that the company currently has no specific plans to invest in AI diagnostic or information technology product companies. Regarding questions about AI technology platforms such as DeepSeek, it is believed that the key lies in the deep integration of technology with actual business scenarios. Although many companies claim to adopt AI technology, achieving efficient integration and addressing practical problems still requires consideration of the following aspects: 1. Technology compatibility: AI technology needs to be highly compatible with the company's core business scenarios. For example, in the medical field, AI technology must possess high precision and high availability.
Mike Biotech: 2024 Annual Results Forecast
Not Many Are Piling Into Maccura Biotechnology Co.Ltd (SZSE:300463) Just Yet